These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14745124)

  • 1. [A new paradigm for the progression of advanced heart failure].
    Kawada T; Nakazawa M; Toyo-oka T
    Nihon Yakurigaku Zasshi; 2004 Feb; 123(2):55-62. PubMed ID: 14745124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel scheme of dystrophin disruption for the progression of advanced heart failure.
    Kawada T; Masui F; Tezuka A; Ebisawa T; Kumagai H; Nakazawa M; Toyo-Oka T
    Biochim Biophys Acta; 2005 Aug; 1751(1):73-81. PubMed ID: 16054019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel paradigm for therapeutic basis of advanced heart failure--assessment by gene therapy.
    Kawada T; Masui F; Kumagai H; Koshimizu M; Nakazawa M; Toyo-Oka T
    Pharmacol Ther; 2005 Jul; 107(1):31-43. PubMed ID: 15963350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction.
    Toyo-Oka T; Kawada T; Nakata J; Xie H; Urabe M; Masui F; Ebisawa T; Tezuka A; Iwasawa K; Nakajima T; Uehara Y; Kumagai H; Kostin S; Schaper J; Nakazawa M; Ozawa K
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7381-5. PubMed ID: 15128945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.
    Kawada T; Nakazawa M; Nakauchi S; Yamazaki K; Shimamoto R; Urabe M; Nakata J; Hemmi C; Masui F; Nakajima T; Suzuki J; Monahan J; Sato H; Masaki T; Ozawa K; Toyo-Oka T
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):901-6. PubMed ID: 11805334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.
    Sakamoto A; Ono K; Abe M; Jasmin G; Eki T; Murakami Y; Masaki T; Toyo-oka T; Hanaoka F
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13873-8. PubMed ID: 9391120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by delta-sarcoglycan gene transfer in vivo.
    Kawada T; Nakatsuru Y; Sakamoto A; Koizumi T; Shin WS; Okai-Matsuo Y; Suzuki J; Uehara Y; Nakazawa M; Sato H; Ishikawa T; Toyo-oka T
    FEBS Lett; 1999 Sep; 458(3):405-8. PubMed ID: 10570949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy prevents disruption of dystrophin-related proteins in a model of hereditary dilated cardiomyopathy in hamsters.
    Toyo-oka T; Kawada T; Xi H; Nakazawa M; Masui F; Hemmi C; Nakata J; Tezuka A; Iwasawa K; Urabe M; Monahan J; Ozawa K
    Heart Lung Circ; 2002; 11(3):174-81. PubMed ID: 16352094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy.
    Kawada T; Sakamoto A; Nakazawa M; Urabe M; Masuda F; Hemmi C; Wang Y; Shin WS; Nakatsuru Y; Sato H; Ozawa K; Toyo-oka T
    Biochem Biophys Res Commun; 2001 Jun; 284(2):431-5. PubMed ID: 11394897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction.
    Yoshida H; Takahashi M; Koshimizu M; Tanonaka K; Oikawa R; Toyo-oka T; Takeo S
    Cardiovasc Res; 2003 Aug; 59(2):419-27. PubMed ID: 12909325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters.
    Ikeda Y; Martone M; Gu Y; Hoshijima M; Thor A; Oh SS; Peterson KL; Ross J
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1362-70. PubMed ID: 10749734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.
    Kawada T; Hemmi C; Fukuda S; Tezuka A; Iwasawa K; Nakazawa M; Sato H; Toyo-Oka T
    Exp Clin Cardiol; 2003; 8(2):67-70. PubMed ID: 19641652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy.
    Franz WM; Müller M; Müller OJ; Herrmann R; Rothmann T; Cremer M; Cohn RD; Voit T; Katus HA
    Lancet; 2000 May; 355(9217):1781-5. PubMed ID: 10832829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
    Lee GH; Badorff C; Knowlton KU
    Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster.
    Mitsuhashi S; Saito N; Watano K; Igarashi K; Tagami S; Shima H; Kikuchi K
    J Biochem; 2003 Aug; 134(2):269-76. PubMed ID: 12966077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatic gene therapy of dilated cardiomyopathy].
    Kawada T; Nakazawa M; Toyo-Oka T
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):37-44. PubMed ID: 11862755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system.
    Imamura M; Araishi K; Noguchi S; Ozawa E
    Hum Mol Genet; 2000 Dec; 9(20):3091-100. PubMed ID: 11115854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.
    Straub V; Duclos F; Venzke DP; Lee JC; Cutshall S; Leveille CJ; Campbell KP
    Am J Pathol; 1998 Nov; 153(5):1623-30. PubMed ID: 9811355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
    Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
    Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.